Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to $277546.0.

  • GeoVax Labs' Share-based Compensation rose 11362.35% to $277546.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 5403.22%. This contributed to the annual value of $528644.0 for FY2024, which is 5082.18% down from last year.
  • Latest data reveals that GeoVax Labs reported Share-based Compensation of $277546.0 as of Q3 2025, which was up 11362.35% from $292740.0 recorded in Q2 2025.
  • In the past 5 years, GeoVax Labs' Share-based Compensation registered a high of $297947.0 during Q3 2023, and its lowest value of $76790.0 during Q1 2021.
  • Its 5-year average for Share-based Compensation is $196773.3, with a median of $207178.0 in 2022.
  • As far as peak fluctuations go, GeoVax Labs' Share-based Compensation soared by 117983.33% in 2021, and later tumbled by 6228.75% in 2024.
  • Quarter analysis of 5 years shows GeoVax Labs' Share-based Compensation stood at $120684.0 in 2021, then soared by 108.13% to $251179.0 in 2022, then rose by 4.09% to $261458.0 in 2023, then tumbled by 46.7% to $139345.0 in 2024, then skyrocketed by 99.18% to $277546.0 in 2025.
  • Its Share-based Compensation stands at $277546.0 for Q3 2025, versus $292740.0 for Q2 2025 and $292744.0 for Q1 2025.